{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:03:30Z","timestamp":1781625810836,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002759","name":"CARES Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ecl.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:31:26Z","timestamp":1771590686000},"page":"201-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update in Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia"],"prefix":"10.1016","volume":"55","author":[{"given":"Athanasia","family":"Bouliari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Lekarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lin-Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2026.01.001_bib1","doi-asserted-by":"crossref","unstructured":"Fechner PY. Disorders of the Adrenal Gland. In: Gleason CAS, Taylor, editor. Avery\u2019s Diseases of the Newborn. 11 ed. Elsevier; 2024:1201-1214.e6.","DOI":"10.1016\/B978-0-323-82823-9.00084-2"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.001_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ecl.2015.02.001","article-title":"Development of adrenal cortex zonation","volume":"44","author":"Xing","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/archdischild-2017-313873","article-title":"Update on adrenal steroid hormone biosynthesis and clinical implications","volume":"104","author":"Bacila","year":"2019","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.001_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.20945\/2359-3997000000438","article-title":"Classic and current concepts in adrenal steroidogenesis: a reappraisal","volume":"66","author":"Kater","year":"2022","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.001_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ecl.2015.02.002","article-title":"Adrenal steroidogenesis and congenital adrenal hyperplasia","volume":"44","author":"Turcu","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2026.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106075","article-title":"The association between the cortisol and cortisone awakening responses","volume":"152","author":"Anderson","year":"2023","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tem.2017.09.002","article-title":"Steroidogenesis: unanswered questions","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000198","article-title":"The \u201cbackdoor pathway\u201d of androgen synthesis in human male sexual development","volume":"17","author":"Miller","year":"2019","journal-title":"PLoS Biol"},{"issue":"44","key":"10.1016\/j.ecl.2026.01.001_bib9","doi-asserted-by":"crossref","first-page":"22294","DOI":"10.1073\/pnas.1906623116","article-title":"Alternative pathway androgen biosynthesis and human fetal female virilization","volume":"116","author":"Reisch","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2026.01.001_bib10","doi-asserted-by":"crossref","unstructured":"Pyeritz RE. Genetic Disorders of the Adrenal Gland. In: Rimoin DLaPREaK, Bruce, editor. Emery and Rimoin\u2019s Principles and Practice of Medical Genetics. 6th edition. Academic Press; 2013:1-37.","DOI":"10.1016\/B978-0-12-383834-6.00087-2"},{"key":"10.1016\/j.ecl.2026.01.001_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000321215","article-title":"P450 side-chain cleavage deficiency--a rare cause of congenital adrenal hyperplasia","volume":"20","author":"Hauffa","year":"2011","journal-title":"Endocr Dev"},{"issue":"Pt A","key":"10.1016\/j.ecl.2026.01.001_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2016.04.014","article-title":"The impact of genetic steroid disorders on human fertility","volume":"165","author":"Reichman","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ecl.2026.01.001_bib13","series-title":"Disorders in the initial steps in steroidogenesis. Genetic steroid disorders (second edition)","first-page":"217","author":"Walter","year":"2023"},{"key":"10.1016\/j.ecl.2026.01.001_bib14","series-title":"Genetic steroid disorders","first-page":"239","article-title":"P450 oxidoreductase deficiency","author":"Flueck","year":"2023"},{"issue":"5","key":"10.1016\/j.ecl.2026.01.001_bib15","first-page":"266","article-title":"Genetic and clinical features of p450 oxidoreductase deficiency","volume":"69","author":"Scott","year":"2008","journal-title":"Horm Res"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.001_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-007-9056-y","article-title":"P450 oxidoreductase deficiency and Antley-Bixler syndrome","volume":"8","author":"Arlt","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.001_bib17","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz255","article-title":"P450 oxidoreductase deficiency: a systematic review and meta-analysis of genotypes, phenotypes, and their relationships","volume":"105","author":"Dean","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2026.01.001_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867073","article-title":"Genotype, mortality, morbidity, and outcomes of 3beta-Hydroxysteroid dehydrogenase deficiency in Algeria","volume":"13","author":"Ladjouze","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ecl.2026.01.001_bib19","series-title":"3\u03b2-Hydroxysteroid dehydrogenase deficiency. Genetic steroid disorders","first-page":"81","author":"Roucher-Boulez","year":"2023"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.001_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12020-018-01835-3","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase type 2 deficiency","volume":"63","author":"Al Alawi","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2026.01.001_bib21","series-title":"Genetic steroid disorders","first-page":"95","article-title":"Genetic deficiencies of cytochrome P450c17 (CYP17A1) combined 17-hydroxylase\/17,20-lyase deficiency and isolated 17,20-lyase deficiency","author":"Auchus","year":"2023"},{"key":"10.1016\/j.ecl.2026.01.001_bib22","series-title":"StatPearls [Internet]","article-title":"17-hydroxylase deficiency","author":"Chormanski","year":"2025"},{"key":"10.1016\/j.ecl.2026.01.001_bib23","series-title":"Steroid 11 beta-hydroxylase deficiency and related disorders. Genetic steroid disorders","first-page":"63","author":"White","year":"2023"},{"key":"10.1016\/j.ecl.2026.01.001_bib24","series-title":"Congenital adrenal hyperplasia. Genetic diagnosis of endocrine disorders","first-page":"203","author":"Yau","year":"2015"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.001_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yapd.2024.02.006","article-title":"Current advances in the management of congenital adrenal hyperplasia","volume":"71","author":"Bouliari","year":"2024","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.ecl.2026.01.001_bib26","series-title":"StatPearls [Internet]","article-title":"21-hydroxylase deficiency","author":"Burdea","year":"2025"},{"key":"10.1016\/j.ecl.2026.01.001_bib27","series-title":"Genetic steroid disorders","first-page":"36","article-title":"Congenital adrenal hyperplasia owing to 21-Hydroxylase deficiency","author":"New","year":"2023"},{"issue":"7","key":"10.1016\/j.ecl.2026.01.001_bib28","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.ecl.2026.01.001_bib29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ecl.2026.01.001_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12093128","article-title":"Clinical update on congenital adrenal hyperplasia: recommendations from a multidisciplinary adrenal program","volume":"12","author":"Uslar","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.ecl.2026.01.001_bib31","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2026.01.001_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1433378","article-title":"Relationship between adipokines and androgens in children and young adults with congenital adrenal hyperplasia","volume":"15","author":"Apsan","year":"2024","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.001_bib33","doi-asserted-by":"crossref","first-page":"e3850","DOI":"10.1210\/clinem\/dgaf123","article-title":"Bone mineral density in patients with congenital adrenal hyperplasia from prepubertal to adult age","volume":"110","author":"Stancampiano","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.001_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11657-022-01090-0","article-title":"Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency","volume":"17","author":"Lee","year":"2022","journal-title":"Arch Osteoporos"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.001_bib35","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.001_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ecl.2015.07.009","article-title":"Infertility and reproductive function in patients with congenital adrenal hyperplasia: pathophysiology, advances in management, and recent outcomes","volume":"44","author":"Lekarev","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.001_bib37","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/clinem\/dgaa023","article-title":"Brain differences in the prefrontal cortex, amygdala, and hippocampus in youth with congenital adrenal hyperplasia","volume":"105","author":"Herting","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2026.01.001_bib38","doi-asserted-by":"crossref","unstructured":"Yamashita NL, Deras EA, O\u2019Neil SH, et al. Cognitive function worsens with increasing age and glucocorticoid dose in classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Presented at: Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025; 2025; Copenhagen, Denmark.","DOI":"10.1530\/endoabs.110.P177"},{"key":"10.1016\/j.ecl.2026.01.001_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psyneuen.2015.06.017","article-title":"Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study","volume":"60","author":"Engberg","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.001_bib40","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1210\/jc.2013-3707","article-title":"Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2026.01.001_bib41","series-title":"GeneReviews((R))","article-title":"21-hydroxylase-deficient congenital adrenal hyperplasia","author":"Nimkarn","year":"1993"},{"key":"10.1016\/j.ecl.2026.01.001_bib42","author":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.001_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/jcem.86.1.7275","article-title":"Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia","volume":"86","author":"Merke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.001_bib44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.001_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000523808","article-title":"Twice daily compared to three times daily hydrocortisone in prepubertal children with congenital adrenal hyperplasia","volume":"95","author":"Apsan","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"Supplement_1","key":"10.1016\/j.ecl.2026.01.001_bib46","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1210\/clinem\/dgae759","article-title":"Future directions in the management of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"110","author":"Sarafoglou","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.001_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/clinem\/dgab749","article-title":"Crinecerfont lowers elevated hormone markers in adults with 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"107","author":"Auchus","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.001_bib48","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1210\/clinem\/dgad270","article-title":"Crinecerfont, a CRF1 receptor antagonist, lowers adrenal androgens in adolescents with congenital adrenal hyperplasia","volume":"108","author":"Newfield","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2026.01.001_bib49","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1210\/clinem\/dgae771","article-title":"Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"110","author":"Al-Rayess","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2026.01.001_bib50","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2026.01.001_bib51","doi-asserted-by":"crossref","first-page":"A83","DOI":"10.1210\/jendso\/bvac150.172","article-title":"OR12-2 inhibition of basal and ACTH-stimulated cortisol secretion in humans using an oral nonpeptide ACTH antagonist (CRN04894)","volume":"6","author":"Betz","year":"2022","journal-title":"J Endocr Soc"},{"issue":"Supplement_1","key":"10.1016\/j.ecl.2026.01.001_bib52","article-title":"12484 safety and pharmacokinetics of Anti-ACTH antibody Lu AG13909 in patients with classic congenital adrenal hyperplasia: phase 1 open-label, multiple-ascending-dose trial protocol","volume":"8","author":"Umasuthan Srirangalingam","year":"2024","journal-title":"J Endocrine Soc"},{"issue":"6","key":"10.1016\/j.ecl.2026.01.001_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852926000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852926000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:51:48Z","timestamp":1781621508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852926000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0889852926000010"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2026.01.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update in Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}